RxDoctor Payments Data

Raymond di Pretoro, DPM

Foot & Ankle Surgery · Newark, DENPI 1568464816

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.8% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Smith+Nephew at 40.4% of the total.

$4,457in general payments, 2019–2025

Across 75 payments — averaging $59.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$2K
  • Stryker$1K
  • Medtronic$554
  • Osteomed LLC$287
  • Organogenesis Inc.$97
  • Bioventus LLC$82
  • plus $330 from 10 others

What the payments were for

  • Food & beverage$4,40599%
  • Education$521%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,457 in reported general payments places this provider in the 65th percentile of 32 foot & ankle surgery providers in Delaware.

See all foot & ankle surgery providers in Delaware

Medicare billing

Part B allowed, 2024
$292,181
Medicare patients
617
Services billed
3,645

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox43$1,704
Gentamicin Sulfate30$1,338
Gabapentin34$952
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc13$672
Ketoconazole35$660
Fluconazole26$500
Allopurinol39$476
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav25$395
Cephalexin30$309
Doxycycline Hyclate14$134
Mupirocin20$105
Ciprofloxacin Hcl16$86
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$69
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen18$56
Acetaminophen-CodeineAcetaminophen With Codeine22$45

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Newark

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →